Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents		$ 6	$ 2
Other accounts receivable and prepaid expenses		7	20
Total current assets		13	22
TOTAL ASSETS		13	22
Current Liabilities
Accrued expenses and other payables		187	157
Related Parties		108
Total current liabilities		295	157
Long term liabilities
Related Parties			103
Total Liabilities		295	260
Shareholders' equity
Common stock, $0.01 par value - authorized: 51,000,000; issued and outstanding: 5,153,461 as of September 30, 2020 and December 31, 2019		52	52
Additional paid in capital		1,917	1,907
Accumulated deficit		(2,252)	(2,197)
Total stockholders' equity		(283)	(238)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		13	22
Series A Preferred Stock [Member]
Shareholders' equity
Preferred stock	[1]
Series C Preferred Stock [Member]
Shareholders' equity
Preferred stock	[1]

[1] Represents an amount lower than $1,000 USD